Z. Harel

发表

A Contemporary Approach to Dysmenorrhea in Adolescents

Zeev Harel, Z. Harel, 2002, Paediatric drugs.

Approach to the adolescent girl as she transits from irregular to regular menstrual cycles.

Z. Harel, 2005, Journal of pediatric and adolescent gynecology.

Depo-Provera in adolescents: effects of early second injection or prior oral contraception.

F. Biro, L. Kollar, Z. Harel, 1995, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents.

F. Biro, S. Rosenthal, R. Kottenhahn, 1996, American journal of obstetrics and gynecology.

Urinary Leukotriene (LT)- E4 in Adolescents with Dysmenorrhea

J. Drazen, C. Lilly, S. Riggs, 1998 .

Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study.

J. Drazen, C. Lilly, S. Riggs, 2000, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Long-Term Alterations in Growth Hormone and Insulin Secretion after Temporary Dietary Protein Restriction in Early Life in the Rat

G. Tannenbaum, Z. Harel, 1995, Pediatric Research.

Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion.

G. Tannenbaum, Z. Harel, 1992, Endocrinology.

Alterations of human growth hormone binding by rat liver membranes during hypo- and hyperthyroidism.

Z. Hochberg, Z. Harel, T. Bick, 1990, Endocrinology.

Dysmenorrhea in Adolescents

Z. Harel, 2008, Annals of the New York Academy of Sciences.

Dysmenorrhea in adolescents and young adults: etiology and management.

Z. Harel, 2006, Journal of pediatric and adolescent gynecology.

Mini-Review Dysmenorrhea in Adolescents and Young Adults : Etiology and Management

Z. Harel, 2022 .

Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies

Z. Harel, 2012, Expert opinion on pharmacotherapy.

Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies

Z. Harel, 2008, Expert opinion on pharmacotherapy.

C. Gordon, A. DiVasta, B. Cromer, 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Adolescents: At Increased Risk for Osteoporosis?

B. Cromer, Z. Harel, 2000, Clinical pediatrics.

Omega-3 polyunsaturated fatty acids in adolescents: knowledge and consumption.

S. Riggs, Z. Harel, R. Vaz, 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Effects of long term treatment with sertraline (Zoloft) simulating hypothyroidism in an adolescent.

F. Biro, Z. Harel, W. Tedford, 1995, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Adolescents and calcium: what they do and do not know and how much they consume.

S. Riggs, Z. Harel, R. Vaz, 1998 .

Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone.

Z. Hochberg, M. Silbermann, D. Lewinson, 1989, Endocrinology.

Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea.

Z. Harel, 2004, Journal of pediatric and adolescent gynecology.

Osteoporosis in Teenagers

E. Quint, Z. Harel, 2002 .

Centrally administered insulin-like growth factor II fails to alter pulsatile growth hormone secretion or food intake.

G. Tannenbaum, Z. Harel, 1992, Neuroendocrinology.

Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa.

S. Riggs, Z. Harel, 1997, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Transdermal Versus Oral Administration of Estrogen in the Management of Lumbar Spine Osteopenia in an Adolescent with Anorexia Nervosa

S. Riggs, Z. Harel, 1997 .

The use of long-acting contraceptives in adolescents.

B. Cromer, Z. Harel, 1999, Pediatric clinics of North America.

Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study.

J. Machan, S. Riggs, P. Flanagan, 2010, Journal of pediatric and adolescent gynecology.

The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.

S. Riggs, P. Flanagan, Z. Harel, 2004, Journal of pediatric and adolescent gynecology.

Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.

M. Gold, L. Bachrach, R. Burkman, 2010, Contraception.

Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.

M. Gold, L. Bachrach, R. Burkman, 2010, Journal of pediatric and adolescent gynecology.

Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.

M. Gold, L. Bachrach, R. Burkman, 2010, Contraception.

Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.

M. Gold, L. Bachrach, R. Burkman, 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Hyperthyroidism in an adolescent with bulimia nervosa.

F. Biro, Z. Harel, 1994, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents.

S. Riggs, Z. Harel, R. Vaz, 2002, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Clinical variability in approaches to polycystic ovary syndrome.

Jill S. Huppert, A. DiVasta, E. Connor, 2012, Journal of pediatric and adolescent gynecology.

Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.

S. Riggs, P. Flanagan, Z. Harel, 2005, Journal of pediatric and adolescent gynecology.

Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

F. Biro, L. Kollar, Z. Harel, 1996, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents.

F. Biro, S. Riggs, P. Flanagan, 2001, Journal of pediatric and adolescent gynecology.

Pseudocyesis in an adolescent using the long-acting contraceptive Depo-Provera.

Z. Harel, P. Flanagan, 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Small bowel obstruction in an adolescent with pelvic inflammatory disease due to Chlamydia trachomatis.

T. Tracy, Z. Harel, J. Bussey, 2003, Journal of pediatric and adolescent gynecology.

Low vitamin D status among obese adolescents: prevalence and response to treatment.

P. Flanagan, M. Forcier, Z. Harel, 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Aromatase p450 expression in a feminizing adrenal adenoma presenting as isosexual precocious puberty.

C. Phornphutkul, P. Gruppuso, Shiuan Chen, 2001, The Journal of clinical endocrinology and metabolism.

Antibodies against human putamen in adolescents with anorexia nervosa.

S. Riggs, J. Hallett, L. Kiessling, 2001, The International journal of eating disorders.

Isolated Low HDL Cholesterol Emerges as the Most Common Lipid Abnormality Among Obese Adolescents

S. Riggs, P. Flanagan, Z. Harel, 2009, Clinical pediatrics.

Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture

K. Rothman, K. Wolter, L. McQuay, 2013, Obstetrics and gynecology.

On the need to screen for Chlamydia and gonorrhea infections prior to colposcopy in adolescents.

S. Riggs, Z. Harel, 1997, Journal of Adolescent Health.

On the Need to Infections Prior Screen for Chlamydia and Gonorrhea to Colposcopy in Adolescents

S. Riggs, Z. Harel, 1997 .

Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies.

Z. Harel, 2008, Expert opinion on pharmacotherapy.

Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.

M. Gold, L. Bachrach, R. Burkman, 2008, Contraception.

Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox.

S. Riggs, Z. Harel, R. Vaz, 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Bone metabolism during adolescence: the known, the unknown, and the controversial.

Z. Harel, 2008, Adolescent medicine: state of the art reviews.

Dysmenorrhea in adolescents and young adults: etiology and management.

Z. Harel, 2006, Journal of pediatric and adolescent gynecology.

Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture

K. Rothman, K. Wolter, L. McQuay, 2013, Journal of Family Planning and Reproductive Health Care.